Intellectual property report on long-acting technologies
Guidelines prevention, reporting and management of wrongdoing
Impact story: Expanding access to next generation drug-resistant tuberculosis treatment
Unitaid’s Impact 2017 Results and Key Performance Indictors
Market and technology landscape: HIV rapid diagnostic tests for self-testing, 4th edition
Impact story: Improving use of tuberculosis diagnostics
Impact story: Improving severe malaria outcomes
Impact story: Accelerating access to seasonal malaria chemoprevention
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Meeting report
Accelerating access to innovative point-of-care HIV diagnostics: Lessons learned from UNICEF
Innovative delivery systems for paediatric medicines technology landscape
Disease Narrative for hepatitis C
Disease narrative for tuberculosis
Disease Narrative for malaria
Disease Narrative for HIV
Hepatitis C diagnostics technology landscape – May 2019
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
HIV/AIDS diagnostics technology landscape
Key Performance Indicators 2011
Unitaid strategy 2010-2012
Key Performance Indicators 2010
Unitaid audited financial report for period 2008-2009
